empty
 
 

2024.07.0113:03:00UTC+00Verrica Pharma Announces Settlement Of Litigation With Dormer Labs - Quick Facts

Verrica Pharmaceuticals (VRCA) has successfully settled its litigation with Dormer Laboratories. As a result of the settlement, Dormer Labs will cease the sale of all cantharidin-containing products in the United States, including its Cantharone and Cantharone Plus brands.

Ted White, Verrica's CEO, commented, "We are pleased to announce the swift settlement with Dormer Labs, which Verrica believes was the largest provider of non-FDA approved cantharidin-containing products in the U.S. market. We anticipate that this resolution will lead to increased patient adoption of the FDA-approved product YCANTH."

For additional health news, visit news.com.

  • Grand Choice
    Contest by
    InstaForex
    InstaForex always strives to help you
    fulfill your biggest dreams.
    JOIN CONTEST
  • Chancy Deposit
    Deposit your account with $3,000 and get $4000 more!
    In July we raffle $4000 within the Chancy Deposit campaign!
    Get a chance to win by depositing $3,000 to a trading account. Having fulfilled this condition, you become a campaign participant.
    JOIN CONTEST
  • Trade Wise, Win Device
    Top up your account with at least $500, sign up for the contest, and get a chance to win mobile devices.
    JOIN CONTEST
  • 30% Bonus
    Receive a 30% bonus every time you top up your account
    GET BONUS


Can't speak right now?
Ask your question in the chat.
Widget callback